![]() |
市场调查报告书
商品编码
1375087
南美洲和中美洲心臟微导管市场预测至 2028 年 - COVID-19 影响和区域分析 - 按适应症(一般週边血管和冠状动脉)和最终用户(医院、专科诊所和门诊手术中心)South & Central America Cardiac Microcatheter Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Indication (General Peripheral Vascular and Coronary) and End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers) |
南美洲和中美洲心臟微导管市场预计将从2023年的2,269万美元成长到2028年的3,042万美元。预计2023年至2028年的复合年增长率为6.0%。
越来越多地使用经皮冠状动脉介入治疗 (PCI) 来治疗慢性完全阻塞 (CTO),推动南美洲和中美洲心臟微导管市场的成长
经皮冠状动脉介入治疗(PCI)是治疗慢性完全阻塞(CTO)最困难的手术之一,需要成功达到CTO的再通。此外,CTO是一条或多根冠状动脉的完全或接近完全阻塞。由于冠状动脉内斑块积聚,阻塞通常持续约三个月。过去十年来,随着新颖产品的推出和批准,这一领域取得了重大进展。然而,随着微导管被用作冠状动脉介入工具,新技术设备的推出和策略改进仍在对抗 CTO 的程序中受到监控。该工具为复杂的冠状动脉介入治疗提供了一种治疗方法,例如分叉病变、曲折的解剖结构、孔口位置、冠状动脉钙化、倾斜起飞和 CTO。 Terumo 的 FineCross MG 微导管整合了交叉能力和导丝支持,用于治疗具有挑战性的病例,包括弯曲血管、CTO、分叉以及严重狭窄和钙化病变。因此,越来越多地使用 PCI 来治疗 CTO,从而促进了心臟微导管市场的成长。
南美洲和中美洲心臟微导管市场概述
南美洲和中美洲心臟微导管市场分为阿根廷、巴西以及南美洲和中美洲其他地区。该地区在南美洲和中美洲心臟微导管市场中占据重要地位,预计在预测期内将实现可观的成长率。心血管疾病盛行率的增加、政府措施的增加以及该地区产品推出和批准的激增等驱动因素正在加速南美洲和中美洲心臟微导管市场的成长。
南美洲及中美洲心臟微导管市场收入及 2028 年预测(百万美元)
南美洲和中美洲心臟微导管市场细分
南美洲和中美洲心臟微导管市场分为适应症、最终用户和国家。
根据适应症,南美洲和中美洲心臟微导管市场分为一般週边血管和冠状动脉。 2023 年,冠状动脉细分市场在南美洲和中美洲心臟微导管市场中占据更大份额。
根据最终用户,南美洲和中美洲心臟微导管市场分为医院、专科诊所和门诊手术中心。 2023 年,医院细分市场在南美洲和中美洲心臟微导管市场中占据最大份额。
根据国家/地区,南美洲和中美洲心臟微导管市场分为巴西、阿根廷以及南美洲和中美洲其他地区。 2023年,巴西在南美洲和中美洲心臟微导管市场份额中占据主导地位。
波士顿科学公司;整数控股公司;美敦力公司;梅里特医疗系统公司;和 Teleflex Inc 是南美洲和中美洲心臟微导管市场的领先公司。
The South & Central America cardiac microcatheter market is expected to grow from US$ 22.69 million in 2023 to US$ 30.42 million by 2028. It is estimated to record a CAGR of 6.0% from 2023 to 2028.
Growing Use of Percutaneous Coronary Intervention (PCI) for Treating Chronic Total Occlusions (CTO) Fuels South & Central America Cardiac Microcatheter Market Growth
Percutaneous coronary intervention (PCI) is one of the most difficult procedures for treating of chronic total occlusions (CTO), resulting in successful recanalization of CTO. Further, CTO is complete or near-complete blockage of one or more coronary arteries. The blockage usually lasts approximately three months due to plaque build-up within a coronary artery. Significant progress has been made in this area over the past decade, given the novel product launches and approvals. However, the launch of new technical devices and strategic refinements are still being monitored in the procedures to combat CTOs as the microcatheters are used as a coronary interventional tool. This tool provides a therapeutic approach to complex coronary interventions such as bifurcation lesions, tortuous anatomy, ostial location, coronary calcification, angled takeoffs, and CTO. Terumo's FineCross MG microcatheter integrates cross ability and guidewire support for treating challenging cases including tortuous vessels, CTOs, bifurcations, as well as severely stenosed and calcified lesions. Therefore, the growing usage of PCIs for treating CTO is catalyzing the cardiac microcatheter market growth.
South & Central America Cardiac Microcatheter Market Overview
The South & Central America cardiac microcatheter market is segmented into Argentina, Brazil, and the Rest of South & Central America. The region occupies a significant position in the South & Central America cardiac microcatheter market and is expected to record a promising growth rate during the forecast period. Drivers such as increase in prevalence of cardiovascular disease, rise in government initiatives, and upsurge in launches and approvals of products in the region are accelerating the South & Central America cardiac microcatheter market growth.
South & Central America Cardiac Microcatheter Market Revenue and Forecast to 2028 (US$ Million)
South & Central America Cardiac Microcatheter Market Segmentation
The South & Central America cardiac microcatheter market is segmented into indication, end user, and country.
Based on indication, the South & Central America cardiac microcatheter market is segmented into general peripheral vascular and coronary. The coronary segment held a larger share of the South & Central America cardiac microcatheter market in 2023.
Based on end user, the South & Central America cardiac microcatheter market is segmented into hospitals, specialty clinics, and ambulatory surgical centers. The hospitals segment held the largest share of the South & Central America cardiac microcatheter market in 2023.
Based on country, the South & Central America cardiac microcatheter market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the share of the South & Central America cardiac microcatheter market in 2023.
Boston Scientific Corp; Integer Holdings Corp; Medtronic Plc; Merit Medical Systems Inc; and Teleflex Inc are the leading companies operating in the South & Central America cardiac microcatheter market.